134 related articles for article (PubMed ID: 37651587)
1. Levomethadone Therapeutic Drug Monitoring to Aid Opioid Withdrawal Therapy: A Short Communication.
Pfeifer P; Hildebrand K; Angelov A; Havemann-Reinecke U; Böttcher M; Hiemke C; Prentice T; Roll SC
Ther Drug Monit; 2023 Dec; 45(6):772-776. PubMed ID: 37651587
[TBL] [Abstract][Full Text] [Related]
2. Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment.
Schuster R; Kleimann A; Rehme MK; Taschner L; Glahn A; Groh A; Frieling H; Lichtinghagen R; Hillemacher T; Bleich S; Heberlein A
Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):33-40. PubMed ID: 26801497
[TBL] [Abstract][Full Text] [Related]
3. Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
Casati A; Piontek D; Pfeiffer-Gerschel T
Subst Abuse Treat Prev Policy; 2014 May; 9():19. PubMed ID: 24885218
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine for managing opioid withdrawal.
Gowing L; Ali R; White JM; Mbewe D
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
[TBL] [Abstract][Full Text] [Related]
5. Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway.
Chalabianloo F; Fadnes LT; Høiseth G; Ohldieck C; Vold JH; Aas C; Løberg EM; Johansson KA; Bramness JG
Subst Abuse Treat Prev Policy; 2021 May; 16(1):39. PubMed ID: 33941217
[TBL] [Abstract][Full Text] [Related]
6. Management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
[No Abstract] [Full Text] [Related]
7. [Methadone and levomethadone - dosage and side effects].
Schoofs N; Riemer T; Bald LK; Heinz A; Gallinat J; Bermpohl F; Gutwinski S
Psychiatr Prax; 2014 Mar; 41(2):82-7. PubMed ID: 24254424
[TBL] [Abstract][Full Text] [Related]
8. Expanded table: Some drugs for management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
[No Abstract] [Full Text] [Related]
9. Switching a baby from IV levomethadone to IV fentanyl.
Bender HU; Muench HG; Nussbaum CF
J Opioid Manag; 2021; 17(2):181-183. PubMed ID: 33890281
[TBL] [Abstract][Full Text] [Related]
10. Opioid detoxification in pregnancy.
Dashe JS; Jackson GL; Olscher DA; Zane EH; Wendel GD
Obstet Gynecol; 1998 Nov; 92(5):854-8. PubMed ID: 9794682
[TBL] [Abstract][Full Text] [Related]
11. Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment.
Gutwinski S; Schoofs N; Stuke H; Riemer TG; Wiers CE; Bermpohl F
Harm Reduct J; 2016 Feb; 13():7. PubMed ID: 26879120
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of a newly developed 5-mg levomethadone hydrochloride IR tablet (L-Polamidon® 5 mg tablets) in comparison with the 5-mg levomethadone hydrochloride oral solution (L-Polamidon® solution for substitution) as reference product.
Blume HH; Wedemeyer RS; Donath F; Roscher K; Elvert G; Wagner D; Bley O; Vuia A; Todorova-Sanjari M; Villalobos R; Schug B
Int J Clin Pharmacol Ther; 2015 Apr; 53(4):335-44. PubMed ID: 25669614
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E
Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023
[TBL] [Abstract][Full Text] [Related]
14. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
[TBL] [Abstract][Full Text] [Related]
15. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
[TBL] [Abstract][Full Text] [Related]
16. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.
Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J
Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268
[TBL] [Abstract][Full Text] [Related]
17. Methadone dosage for prevention of opioid withdrawal in children.
Siddappa R; Fletcher JE; Heard AM; Kielma D; Cimino M; Heard CM
Paediatr Anaesth; 2003 Nov; 13(9):805-10. PubMed ID: 14617122
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
19. Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats.
Townsend EA; Blough BE; Epstein DH; Negus SS; Shaham Y; Banks ML
Neuropsychopharmacology; 2022 Nov; 47(12):2132-2139. PubMed ID: 35906489
[TBL] [Abstract][Full Text] [Related]
20. A randomized effectiveness trial of methadone, TENS and methadone plus TENS in management of opiate withdrawal symptoms.
Bakhshani NM; Lashkaripour K; Sadjadi SA
J Pak Med Assoc; 2008 Dec; 58(12):667-71. PubMed ID: 19157318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
